August 1, 2013
Vetter, a leading provider of aseptically prefilled drug-delivery systems, operates a state-of-the-art facility at the Illinois Science + Technology Park in suburban Chicago, IL. The site offers a central US location with a domestic and international airline hub. It is uniquely situated in a thriving biopharmaceutical region that offers an established infrastructure and prominent research institutions.
The company’s Chicago site supports preclinical through phase 2 development projects. The 27,000-ft2 facility’s functional areas include microbiology and chemical analysis laboratories; materials preparation; compounding; aseptic cGMP filling for vials, syringes, and cartridges; quality assurance; and seamless transfer to Vetter Commercial Manufacturing.
DeveIoped at the urging of Vetter’s North American clients, the Chicago site supports small-batch, early stage products. Vetter has extensive experience working with biologics, including monoclonal antibodies, peptides, interferons, and vaccines.
Supporting a Faster Time to Market
The Chicago facility provides the Vetter approach to product development, which enables a smooth continuum throughout a product’s life cycle.
Project Management: Across functions and facilities, throughout the development effort, Vetter teams communicate and coordinate using project-management principles. Such a process-driven approach helps keep projects on track and timelines tight. Experienced project managers steer all tasks and processes, which is especially critical in early phase work.
Technology Transfer: Development and commercial teams closely coordinate a product’s transfer from Chicago’s small-scale site to Vetter’s large-scale manufacturing facilities. The Chicago facility already replicates commercial-stage processes to help prevent surprises at market production.
Partnership: Client collaboration is one of Vetter’s distinguishing hallmarks. Vetter works closely with its clients to plan not only for the present, but to set a successful course through registration and long-term market production.
A Full Menu of Development Services
Vetter’s Chicago facility is an expansion of Vetter Development Service, which employs more than 150 personnel in Europe and the United States and supports customer products from preclinical development through market launch. Its service portfolio includes formulation support, clinical trial manufacturing, regulatory support, process development, and analytical services.
Vetter at a Glance
Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges, and vials. With ~3,000 employees worldwide, Vetter holds numerous patents and has longstanding experience in working with regulatory authorities around the world. Vetter’s international success arises from its three interdependent divisions. Vetter Development Service specializes in taking complex compounds from preclinical development through phase 3. Vetter Commercial Manufacturing provides phase 3 clinical manufacturing through global market supply. And Vetter Packaging Solutions helps clients match their drug substance with an appropriate drug-delivery system for the product’s life cycle.
About the Author
Author Details
Dr. David Brett is a product and service manager for Vetter, Eywiesenstrasse 5, 88212 Ravensburg, Germany; 0049-751-3700-0; [email protected]; www.vetter-pharma.com.
You May Also Like
